English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[Ankle prostheses. Mid-term results after Thompson-Richards and STAR prostheses].

Der Orthopäde 1998 March
Thirty-seven patients with 20 cemented Thompson-Richards prostheses and 19 cementless S.T.A.R. prostheses (2 bilateral cases) were followed up after 1-12 years. Rheumatoid arthritis was the main diagnosis in both populations, with females dominating. The investigation was based on the Kofoed ankle score. At follow-up the total scoring improved to 86.9 pts. in S.T.A.R. and to 77.7 pts. in T.R.P. replacement. The radiological examination showed a high rate of radiolucency for the tibial component (53.3%) in cemented T.R.P.; subsidence of talar component was seen in 3 cases with T.R.P. In cementless S.T.A.R. prothesis only 3 cases showed small radiolucent lines of the flat tibial component. Talar subsidence was not seen at all. In T.R.P. we had two revisions due to prothesis loosening and one maleollar fracture, giving a cumulative estimated survival rate of 87% at 12 years. In the S.T.A.R. prosthesis group two revisions had to be performed because of one meniscal breakage and correction of meniscal height. The estimated survival rate at 6 years was 94.3%.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app